General Information of Drug (ID: DMHV5NK)

Drug Name
TOLOXATONE Drug Info
Synonyms
Toloxatone; 29218-27-7; Humoryl; Perenum; 5-(Hydroxymethyl)-3-(m-tolyl)oxazolidin-2-one; Toloxatone [INN]; Delalande 69276; Toloxatonum [INN-Latin]; Toloxatona [INN-Spanish]; 5-(Hydroxymethyl)-3-(3-methylphenyl)-2-oxazolidinone; EINECS 249-522-2; BRN 0527506; 69276 MD; CHEMBL18116; 2-oxazolidinone, 5-(hydroxymethyl)-3-(3-methylphenyl)-; 5-Hydroxymethyl-3-(m-tolyl)-2-oxazolidinone; 5-(Hydroxymethyl)-3-m-tolyl-2-oxazolidinone; Toloxatone (INN); 5-(hydroxymethyl)-3-m-tolyloxazolidin-2-one; 2-Oxazolidinone, 5-hydroxymethyl-3-(m-t
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
34521
ChEBI ID
CHEBI:156575
CAS Number
CAS 29218-27-7
TTD Drug ID
DMHV5NK

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Monoamine oxidase type A (MAO-A) TT3WG5C AOFA_HUMAN Inhibitor [1]
Monoamine oxidase type B (MAO-B) TTGP7BY AOFB_HUMAN Inhibitor [2]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Monoamine oxidase type B (MAO-B) DTT MAOB 9.367 6.907 8.237 8.409
Monoamine oxidase type A (MAO-A) DTT MAOA 7.207 8.159 9.043 7.711
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Monoamine oxidase type B (MAO-B) DTT MAOB 2.65E-02 1.12E-02 0.07
Monoamine oxidase type A (MAO-A) DTT MAOA 8.14E-01 0.05 0.1
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Quercetin as the active principle of Hypericum hircinum exerts a selective inhibitory activity against MAO-A: extraction, biological analysis, and ... J Nat Prod. 2006 Jun;69(6):945-9.
2 3-(1H-Pyrrol-1-yl)-2-oxazolidinones as reversible, highly potent, and selective inhibitors of monoamine oxidase type A. J Med Chem. 2002 Mar 14;45(6):1180-3.